Tumor cells inhibit the activation of ILC2s through up-regulating PD-1 expression.

Chaoyun YinYani PaGuangyu LiQiang ChenXizu WangXijun HeHuangao Zhou

Published in: Immunopharmacology and immunotoxicology (2024)

Our studies demonstrate a new PD-1/PD-L1 axis regulating mechanism on innate immune cells, which provide a useful direction to ILC2s-based immunotherapy to cancer diseases.

Keyphrases

immune response
papillary thyroid
poor prognosis
nk cells
squamous cell
case control
lymph node metastasis
childhood cancer